The post +157 Billion in 24 Hours: Shiba Inu (SHIB) Inflow Wave Ends Rally Expectations appeared on BitcoinEthereumNews.com. Shiba Inu stays down Shiba Inu belowThe post +157 Billion in 24 Hours: Shiba Inu (SHIB) Inflow Wave Ends Rally Expectations appeared on BitcoinEthereumNews.com. Shiba Inu stays down Shiba Inu below

+157 Billion in 24 Hours: Shiba Inu (SHIB) Inflow Wave Ends Rally Expectations

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
  • Shiba Inu stays down
  • Shiba Inu below key thresholds

With a sharp increase in exchange inflows, Shiba Inu is under fresh selling pressure. More than 157 billion SHIB tokens have been added to exchanges in the past day, which usually indicates an increase in the desire to sell rather than hold. Large inflows like these are frequently seen by traders and investors as a sign that the market may be getting ready for more declines.

Shiba Inu stays down

As of this writing, SHIB is trading close to $0.0000055, continuing the downward trend that has dominated its performance for months. The token’s overall structure is still weak, and the recent spike in exchange inflows supports worries that sellers are still in control, even though the token was able to temporarily stabilize following a string of steep declines earlier this year.

SHIB/USDT Chart by TradingView

One of the most obvious indicators of possible distribution is exchange inflows. Large token transfers from private wallets to trading platforms typically indicate that holders are getting ready to sell their holdings. On the other hand, the signal is typically bullish when assets exit exchanges because it indicates accumulation and long-term holding. Thus, the most recent inflow of 157 billion SHIB indicates increasing selling activity throughout the market.

Crypto Market Review: Ethereum (ETH) Hits First Bullish Setup in 2026, Bitcoin Must Get Comfortable in $70,000s, Was Shiba Inu (SHIB) Price Neutralized?

Ripple CTO Emeritus Reacts to XRP Price, Shiba Inu Prints 666% Spike in Futures, Dogecoin Erases Zero — U.Today Crypto Digest

Shiba Inu below key thresholds

This interpretation is supported by the chart’s price action. The medium-term indicators, which are still firmly sloping downward, are among the key moving averages that Shiba Inu is trading well below. This arrangement suggests that any attempts at recovery will probably encounter significant opposition, making sustained upward momentum challenging to attain in the near future.

You Might Also Like

Additionally, volume trends indicate that the market is still cautious. Although there has been active token movement, as evidenced by the recent inflow event, broader participation has not resulted in significant buying pressure. Rather, with sporadic attempts at stabilization, the asset has been declining.

The most important message for investors is that supply pressure is increasing once more. SHIB may see more selling waves if the tokens that have just joined exchanges start to appear on the market. Under such circumstances, the asset might keep experimenting with lower support zones until more robust demand appears.

Source: https://u.today/157-billion-in-24-hours-shiba-inu-shib-inflow-wave-ends-rally-expectations

Market Opportunity
SHIBAINU Logo
SHIBAINU Price(SHIB)
$0.000005395
$0.000005395$0.000005395
+1.02%
USD
SHIBAINU (SHIB) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09